Clinical Practice of Single‐Molecule Real‐Time Sequencing in the Diagnosis of Spinal Muscular Atrophy
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Hua Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetic Center, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein, Real-Time Polymerase Chain Reaction, Sequence Analysis, DNA. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhangzhou.
Abstract (Originalsprache)
Objectives
To investigate the distribution proportions of the SMN1 gene in spinal muscular atrophy (SMA) using single‐molecule real‐time sequencing (SMRT), thereby providing supplementary evidence for SMA genotyping.
Methods
A retrospective analysis was conducted on 771 subjects who underwent both real‐time quantitative PCR and SMRT sequencing tests, followed by statistical analysis.
Results
Among the 771 enrolled individuals, the male‐to‐female ratio was 2:3, with a median age of 31 years. The detection results obtained from real‐time quantitative PCR and SMRT sequencing were consistent. Using SMRT sequencing, the proportions of samples with SMN1 copy numbers 1, 2, 3, and 4 were 2.33% (18/771), 91.18% (703/771), 6.36% (49/771), and 0.13% (1/771), respectively. For SMN2 , the proportions with 0, 1, 2, 3, and 4 copies were 6.10% (47/771), 33.07% (255/771), 57.59% (444/771), 2.98% (23/771), and 0.26% (2/771), respectively. The carrier frequency of SMN1 deletions was 2.33% (18/771). Additionally, we analyzed four SMA patients using SMRT sequencing. The results demonstrate that this technology accurately detects SMN1 and SMN2 copy numbers, providing essential information for patient diagnosis and clinical management.
Conclusion
With results fully concordant with qPCR, SMRT sequencing enables accurate detection of SMN1 and SMN2 copy numbers, providing robust technical support for population‐based prevention, genetic counseling, and clinical management of SMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetic Center, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
ORCID-Profile: Shu-Rong Hong
Förderung
- Natural Science Foundation of Zhangzhou
Zitieren
APA
Wei, H., Zheng, Y. W., Zhang, N. K., Gao, T. L., Zheng, J. X., Li, T. Y., & Hong, S. R. (2026). Clinical Practice of Single‐Molecule Real‐Time Sequencing in the Diagnosis of Spinal Muscular Atrophy. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70314
Vancouver
Wei H, Zheng YW, Zhang NK, Gao TL, Zheng JX, Li TY, et al. Clinical Practice of Single‐Molecule Real‐Time Sequencing in the Diagnosis of Spinal Muscular Atrophy. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70314
BibTeX
@article{Wei2026,
author = {Wei, Hua and Zheng, Ya-Wen and Zhang, Ning-Ke and Gao, Tie-Li and Zheng, Jie-Xiang and Li, Tian-You and Hong, Shu-Rong},
title = {Clinical Practice of Single‐Molecule Real‐Time Sequencing in the Diagnosis of Spinal Muscular Atrophy},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70314}
}
EUVIMED